Arkolith/Insider Trading/CATX/Form 4

Hunt Jonathan Robert

Chief Financial OfficerPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Nov 27, 2024
Net Buying
Open-Market Buys
$49K
Open-Market Sells
$0
Net Open-Market Flow
$49K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2024Buy(P)10K$3.88$39K49K
Nov 25, 2024Buy(P)2K$3.60$9K39K
Nov 25, 2024Buy(P)400$3.55$1K36K
Nov 25, 2024Buy(P)29$3.94$11436K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-131250) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML